SBI Holdings, Inc. : Joint Clinical Research on Diabetes with Arabian
 

21-03-13 02:26 AM

We are pleased to inform you that SBI Pharmaceuticals Co., Ltd. (Head office: Minato-ku, Tokyo; Representative Director and CEO: Yoshitaka Kitao; "SBI Pharmaceuticals"), a subsidiary of SBI Holdings, Inc., which is engaged in research and development of ...

Source...